Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LAPTM4A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PIKFYVE | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | IL17D | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | TCAF1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | FAM47A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | EPS8L2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | GALNT2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | MAP4K2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | PBX1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | DNAH10 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |